[Elsevier] Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Nave Patients

FouadMikhail Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-23 19:28

Reward10points

journal：Clinical Lymphoma Myeloma and Leukemia

Authors：Khalid Halahleh; Suhaib Al Sawajneh; Yacob Saleh; Omar Shahin; Alaa Abufara; Mohamad Ma'koseh; Rashid Abdel-Razeq; Fareed Barakat; Hadeel Abdelkhaleq; Nadira Al-Hassan; Reem Atiyyat; Noor Al-Faker; Zaid Omari; Hamza Ghatasheh; Imad Jaradat; Isa Muradi; Sultan Iyad; Ali Bazarbachi

Published date：2022-8-

DOI：10.1016/j.clml.2022.02.009

PDF link：https://www.sciencedirect.com/sc ... 152265022000660/pdf

Article link：https://doi.org/10.1016/j.clml.2022.02.009

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report